Harel Insurance Investments & Financial Services’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-325
Closed -$14K 858
2020
Q4
$14K Buy
+325
New +$16K ﹤0.01% 681
2019
Q4
Sell
-7,720
Closed -$358K 550
2019
Q3
$358K Buy
7,720
+7,395
+2,275% +$319K 0.02% 146
2019
Q2
$14K Hold
325
﹤0.01% 403
2019
Q1
$14K Buy
325
+265
+442% +$11.4K ﹤0.01% 387
2018
Q4
$3K Hold
60
﹤0.01% 443
2018
Q3
$3K Hold
60
﹤0.01% 466
2018
Q2
$2K Sell
60
-500
-89% -$19.7K ﹤0.01% 451
2018
Q1
$22K Sell
560
-132
-19% -$5.49K ﹤0.01% 386
2017
Q4
$38K Buy
692
+311
+82% +$14.3K ﹤0.01% 357
2017
Q3
$38K Hold
381
﹤0.01% 300
2017
Q2
$36K Buy
381
+377
+9,425% +$18K ﹤0.01% 311
2017
Q1
$0 Sell
4
-377
-99% -$16K ﹤0.01% 476
2016
Q4
$31K Buy
381
+207
+119% +$8.16K ﹤0.01% 224
2016
Q3
$12K Hold
174
﹤0.01% 377
2016
Q2
$15K Hold
174
﹤0.01% 510
2016
Q1
$14K Buy
+174
New +$6.99K ﹤0.01% 325

Other funds holding SNY

Harel Insurance Investments & Financial Services's SNY Position: Q1 2021 in Review

Harel Insurance Investments & Financial Services sold out of Sanofi (SNY) in Q1 2021, closing a stake of 325 shares — an estimated $14K sold.

Harel Insurance Investments & Financial Services first reported a position in SNY in Q1 2016 and held it in 16 quarters. The position peaked at $358K in Q3 2019. 573 funds tracked by Wall St. Rank hold SNY as of Q1 2021.

  • Harel Insurance Investments & Financial Services reported no remaining Sanofi position as of Q1 2021 after selling out during the quarter.
  • Harel Insurance Investments & Financial Services sold 325 Sanofi shares in Q1 2021, an estimated $14K.
  • Harel Insurance Investments & Financial Services first reported a position in Sanofi in Q1 2016 and held it in 16 quarters.
  • Harel Insurance Investments & Financial Services's Sanofi position peaked at $358K in Q3 2019.
  • 573 funds tracked by Wall St. Rank held Sanofi as of Q1 2021.

Based on Harel Insurance Investments & Financial Services's 13F filing for Q1 2021, filed 27 Apr 2021.